A Major Clinical Step Forward: Evaluating the NeuroCuple® Device in Knee Replacement Surgery

When patients undergo a major procedure like total knee arthroplasty (TKA), managing pain safely is critical. Effective pain relief enables mobilization, shorter hospital stays, fewer complications—and, critically today, less reliance on opioid medications. That’s why the ongoing randomized controlled trial NCT06460350 is so important for the device manufacturer, clinicians, and patients alike. What is the Trial? Name: “NEUROCUPLE™ in TKA Patients to Enhance Pain Management” (ClinicalTrials.gov Identifier: NCT06460350) found here --> ClinicalTrials.gov Design: Randomized (1:1), placebo-controlled trial comparing the NeuroCuple® patch versus a look-alike placebo patch (without the active nano-capacitor array) in patients undergoing primary unilateral TKA. Scope: The device…
Read More

Clinical Evidence Update: NeuroCuple® Device Shows Significant Benefits in Postoperative Pain Management

  As postoperative pain management continues to evolve toward safer and more multimodal strategies, clinicians are seeking non-pharmacologic modalities capable of reducing opioid exposure without compromising analgesia or recovery outcomes. A recent peer-reviewed study published in the Journal of Clinical Medicine provides encouraging evidence that the NeuroCuple® device—a passive, battery-free nano-capacitive patch—may serve as a meaningful adjunct in early postoperative care. 🔗 Study link: https://www.mdpi.com/2077-0383/12/23/7394 Study Design Summary Conducted at UPMC Shadyside, this prospective, randomized, open-label pilot trial evaluated the NeuroCuple® device in opioid-naïve adults undergoing unilateral primary TKA or THA. Key elements: Participants randomized postoperatively to: Standard multimodal analgesia…
Read More